Novabase SGPS (XLIS:NBA) Other Stockholders Equity: €-8.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XLIS:NBA Novabase SGPS XLIS:NBA
56 GF Score
Price €7.76
GF Value €4.24
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Novabase SGPS Other Stockholders Equity?

Novabase SGPS XLIS:NBA +3.47% 56 Other Stockholders Equity is €-8.1 Mil as of Dec. 2025. GuruFocus rates XLIS:NBA with a GF Score™ of 56/100 and a GF Value™ of €4.24 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Novabase SGPS's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €-8.1 Mil.

Novabase SGPS's quarterly Other Stockholders Equity declined from Dec. 2024 (€28.5 Mil) to Jun. 2025 (€-14.1 Mil) but then increased from Jun. 2025 (€-14.1 Mil) to Dec. 2025 (€-8.1 Mil).

Novabase SGPS's annual Other Stockholders Equity increased from Dec. 2023 (€27.4 Mil) to Dec. 2024 (€28.5 Mil) but then declined from Dec. 2024 (€28.5 Mil) to Dec. 2025 (€-8.1 Mil).

Novabase SGPS Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Novabase SGPS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novabase SGPS Other Stockholders Equity Chart

Novabase SGPS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.24 16.44 27.45 28.54 -8.06

Novabase SGPS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.45 28.89 28.54 -14.08 -8.06
XLIS:NBA
56GF Score
Novabase SGPS XLIS:NBA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novabase SGPS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-8.1 Mil mean?
Novabase SGPS (XLIS:NBA) has a Other Stockholders Equity of €-8.1 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Novabase SGPS and its competitors.
Is Novabase SGPS's Other Stockholders Equity too high?
Novabase SGPS's current Other Stockholders Equity is €-8.1 Mil. Overall, Novabase SGPS has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Novabase SGPS's Other Stockholders Equity compare to IBM and ACN?
Novabase SGPS's Other Stockholders Equity of €-8.1 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Software company?
A good Other Stockholders Equity depends on the Software industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Novabase SGPS and its competitors. Novabase SGPS's current Other Stockholders Equity is €-8.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novabase SGPS stock overvalued right now?
Based on GuruFocus' analysis, Novabase SGPS (XLIS:NBA) is currently considered Significantly Overvalued. The stock's GF Value™ is €4.24, compared to a current price of €7.76 — trading 83% above its estimated fair value. The current Other Stockholders Equity is €-8.1 Mil. Novabase SGPS's overall GF Score™ is 56/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Novabase SGPS (XLIS:NBA), the current Other Stockholders Equity is €-8.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novabase SGPS (XLIS:NBA) Overvalued in 2026?

Based on GuruFocus' analysis, Novabase SGPS stock appears to be overvalued. The current stock price of €7.76 is trading 83% above its estimated GF Value™ of €4.24. GuruFocus considers Novabase SGPS to be Significantly Overvalued.

Key valuation signals for XLIS:NBA:

  • Other Stockholders Equity: €-8.1 Mil
  • GF Value™: €4.24 vs. price of €7.76 (83% above fair value)
  • GF Score™: 56/100 with 2 warning signs

No single metric tells the full story. See the XLIS:NBA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Novabase SGPS Business Description

Other Exchanges 0MTZ:UKNVQ:Germany
Address Avenida D Joao II, 34, Parque das Nacoes, Lisbon, PRT, 1998-031
Novabase SGPS is engaged in holding and managing financial holdings in other companies. The Group operates through two business areas: Next-Gen (NG), which generates maximum revenue and operates under the Celfocus commercial brand, providing IT consulting and services focused on the Financial Services and Telecommunications industries across Europe and the Middle East; and Value Portfolio (VP), which develops venture capital activities. The Next-Gen and IT Service segment focuses on Design & UX, insights through data, native & scalable cloud, digital architecture, exposure to APIs, AI/Analytics, automation of tests & engineering, continuous delivery, and intelligent operations. The Group operates in Portugal, Europe, the Middle East, and Africa.
56GF Score

Get the complete analysis for XLIS:NBA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.76
Price
€4.24
GF Value